SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $6,661,817,069 |
| Positions | 109 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | PRAX | COM NEW | $681,627,753 | 2,035,986 |
| SPYRE THERAPEUTICS INC | SYRE | COM NEW | $383,484,855 | 4,319,496 |
| CELCUITY INC | CELC | COM | $334,491,064 | 3,197,200 |
| ASCENDIS PHARMA A/S | ASND | ORD SHS | $310,387,665 | 1,163,721 |
| RHYTHM PHARMACEUTICALS INC | RYTM | COM | $287,156,334 | 2,586,295 |
| ROIVANT SCIENCES LTD | ROIV | SHS | $286,144,465 | 8,085,461 |
| RELAY THERAPEUTICS INC | RLAY | COM | $263,926,759 | 14,106,187 |
| TRAVERE THERAPEUTICS INC | TVTX | COM | $213,183,729 | 3,752,574 |
| KARDIGAN INC | KARD | COM | $195,585,788 | 8,200,662 |
| NUVALENT INC | NUVL | COM | $195,192,368 | 1,580,505 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.